Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo

Clinical Trial Description

n/a

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Screening

See also
Status	Clinical Trial	Phase
Completed	`NCT04094012` - Risk of SDRs Under 3HP and 1HP Regimen for LTBI	Phase 3
Completed	`NCT01582711` - Study 33: Adherence to Latent Tuberculosis Infection Treatment 3HP SAT Versus 3HP DOT	Phase 3
Recruiting	`NCT06033807` - Active Screening of Latent Tuberculosis Infection in School Contacts of Active Tuberculosis Patients
Completed	`NCT01622140` - Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis
Completed	`NCT00557765` - Use of a Gamma-IFN Assay in Contact Tracing for Tuberculosis in a Low-Incidence, High Immigration Area	N/A
Completed	`NCT00463086` - Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons	N/A
Active, not recruiting	`NCT01398618` - Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)	Phase 3
Recruiting	`NCT00905970` - Demonstration of the Dynamic Hypothesis of Latent Tuberculosis Infection	N/A
Recruiting	`NCT00449345` - Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness Analysis	N/A
Completed	`NCT02641106` - VDOT for Monitoring Adherence to LTBI Treatment	N/A
Completed	`NCT00804713` - Screening for Latent Tuberculosis Infection (LTBI) in US Army Recruits	N/A
Completed	`NCT01136161` - Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection	Phase 2
Recruiting	`NCT03312647` - Adverse Drug Reactions to Anti-TB Drugs in the Treatment of Latent Tuberculosis Infection	N/A
Completed	`NCT02810678` - Enhancing the Public Health Impact of Latent Tuberculosis (TB) Infection Diagnosis and Treatment	N/A
Completed	`NCT01223534` - QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.	Phase 4
Withdrawn	`NCT00558480` - Vitamin A Supplementation for Modulation of Mycobacterium Tuberculosis Immune Responses in Latent Tuberculosis	N/A
Recruiting	`NCT00692809` - Impact of HIV Infection on Latent Tuberculosis (TB) Among Patients With HIV-TB Co-infection	N/A
Completed	`NCT03702049` - Nurse-Led Community Health Worker Adherence Model in 3HP Delivery Among Homeless Adults at Risk for TB Infection and HIV	N/A
Terminated	`NCT01761201` - "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients".	Phase 3
Completed	`NCT01608685` - Interferon Gamma Release Assays (IGRA) Testing Versus Tuberculin Skin Test in Renal Transplant Recipients	N/A

NCT number	NCT01007396
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	N/A
Start date	January 2008
Completion date	December 2009

Diagnosis of Tuberculosis Infection in Health Care Workers Using Ex-vivo Interferon-gamma Assay

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms